A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people ...
The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.
Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center have identified a distinct type of prostate cell ...
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...
A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.
Through long-standing research, which has been supported by the National Institutes of Health, investigators at Johns Hopkins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results